Secondary Immune Deficiency research hub

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

This study looks at a medicine called IgPro20 for adults with weakened immune systems due to cancer treatments. It checks if IgPro20 can reduce serious infections and if it's safe. This could help people after certain cell therapies.